Calamos S&P 500 Structured Alt Protection ETF - March CPSR
Set alert
As of Oct 30, 10:00 AM ET
- YTD
- +4.22%
- 1 year
- +5.40%
- Open
- 26.25
- Prev close
- 26.31
- Mkt cap
- 253.92M
- Vol
- 78
- Avg vol
- 1.39K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 26.25
- High
- 26.25
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 1.21
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 9.77
- 200-d avg
- 9.84
- 1y target
- 0.00
News
2 months ago zacks.com
Calamos S&P 500 ETF (CPSR) Touches Fresh 52-Week High
CPSR hits a fresh 52-week high as investors seek upside linked to the S&P 500 with full downside protection over a year.
1 year ago benzinga.com
Calamos' New ETFs Promise Market Exposure Without The Meltdowns
Calamos added 2 new Structured Protection ETFs in April, providing exposure to S&P 500 and Russell 2000 with downside protection and capped gains.
4 years ago benzinga.com
Gelesis, Maker Of Weight Loss Pill, Concludes SPAC Deal; Trading Kickstarts Today
PureTech Health plc (NASDAQ: PRTC) founded entity Gelesis Inc, maker of weight management aid, has completed its business combination with Capstar Special Purpose Acquisition Corp (NYSE: CPSR). The…
-
4 years ago benzinga.com
Gelesis, Maker Of Weight Loss Pill, Concludes SPAC Deal; Trading Kickstarts Today
PureTech Health plc (NASDAQ: PRTC) founded entity Gelesis Inc, maker of weight management aid, has
4 years ago businesswire.com
Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with Capstar
BOSTON & AUSTIN, Texas--(BUSINESS WIRE)--Gelesis, the maker of Plenity®, an FDA-cleared weight management approach, announced today the completion of its business combination with Capstar Special…
-
4 years ago benzinga.com
48 Biggest Movers From Yesterday
Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT performance drink in Walmart…
-
4 years ago benzinga.com
30 Stocks Moving In Tuesday's Mid-Day Session
Gainers TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's morning trading, 87 companies set new 52-week lows.
-
4 years ago benzinga.com
45 Stocks Moving In Monday's Mid-Day Session
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88.
4 years ago businesswire.com
Gelesis Adds Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee
BOSTON--(BUSINESS WIRE)--Gelesis, a biotherapeutics company focused on excess weight and metabolic disorders and the maker of Plenity®, announced the appointment of senior financial executive Ali…
4 years ago businesswire.com
Have Your Cake and Eat It Too: Plenity® Creates Edible Dessert Billboard to Challenge Overly Restrictive Dieting Assumptions
BOSTON--(BUSINESS WIRE)--Gelesis, the maker of Plenity®, an FDA-cleared weight management approach, has created an edible billboard in New York City’s Astor Place to challenge the idea that people…
4 years ago businesswire.com
Gelesis’ FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer
BOSTON--(BUSINESS WIRE)--Gelesis, a consumer-focused biotherapeutics company, is proud to announce Plenity®, an FDA cleared weight management approach, is now broadly available across the United…
-
4 years ago benzinga.com
PureTech Founded Entity Gelesis Receives $30M Plenity Order From Ro
PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)))) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, announced today that its Founded Entity, Gelesis, Inc.
4 years ago businesswire.com
Gelesis Receives $30 Million Plenity Order from Ro
BOSTON--(BUSINESS WIRE)--Gelesis announced today that leading U.S. direct-to-patient healthcare company Ro has placed a $30 million fully paid pre-order for the company’s first commercial product for…
-
4 years ago benzinga.com
Capstar Special Purpose Acquisition Corp. Reports Terms Of Deal With Gelesis Revised To Imply Equity Value Of $675M, Down From $900M
Capstar Special Purpose Acquisition Corp. (NYSE:CPSR) (“Capstar”), a special purpose acquisition company, announced that the valuation of its previously announced transaction with Gelesis, Inc.
-
5 years ago benzinga.com
Capstar Special Purpose Acquisition Merging Partner Gelesis Announces Nature's Scientific Reports Features Gelesis' Novel and Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage
New paper describes the first superabsorbent hydrogel technology made from naturally derived building blocks designed to address obesity and gut related conditions by emulating compositional and…
5 years ago businesswire.com
Nature’s Scientific Reports Features Gelesis’ Novel and Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage
BOSTON--(BUSINESS WIRE)--Gelesis, a consumer-focused biotherapeutics company and the maker of Plenity®, announced today a publication in Nature’s Scientific Reports describing the genesis of the…
5 years ago businesswire.com
Two Senior Scientific Leaders at Gelesis Awarded Top Industry Honors
BOSTON--(BUSINESS WIRE)--Gelesis, a consumer-focused biotherapeutics company and the maker of Plenity®, announced that two senior leaders in the company, Elaine Chiquette, Pharm.D., and Elizabeth…
5 years ago benzinga.com
FDA-Approved Weight Loss Drug Plenity's Parent Announces SPAC Deal: What Investors Should Know
A SPAC deal announced Monday could help accelerate the manufacturing of a promising weight loss drug targeting over 150 million people. The SPAC Deal: Gelesis announced a SPAC merger with Capstar…
-
5 years ago benzinga.com
FDA-Approved Weight Loss Drug Plenity's Parent Announces SPAC Deal: What Investors Should Know
A SPAC deal announced Monday could help accelerate the manufacturing of a promising weight loss drug targeting over 150 million people.
5 years ago businesswire.com
Gelesis, a Consumer-Focused Biotherapeutics Company and the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.
BOSTON & AUSTIN, Texas--(BUSINESS WIRE)--Gelesis, Inc. (“Gelesis” or the “Company”), a biotherapeutics company advancing biomimetic superabsorbent hydrogels to treat excess weight and metabolic…
5 years ago businesswire.com
Gelesis, a Consumer-Focused Biotherapeutics Company and the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.
BOSTON & AUSTIN, Texas--(BUSINESS WIRE)--Gelesis, Inc. (“Gelesis” or the “Company”), a biotherapeutics company advancing biomimetic superabsorbent hydrogels to treat excess weight and metabolic…
5 years ago businesswire.com
Capstar Special Purpose Acquisition Corp. Receives Expected Notice from NYSE Regarding Delayed Quarterly Report
AUSTIN, Texas--(BUSINESS WIRE)--Capstar Special Purpose Acquisition Corp. (NYSE:CPSR.U; CPSR; CPSR WS) (the “Company”) today announced that, as expected, on May 25, 2021 it received a notice from the…
-
5 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 92 stocks hit new 52-week lows.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Friday's session saw 466 companies set new 52-week highs.